rtki cpd and Cancer of Nasopharynx

rtki cpd has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, GK; Li, ZM; Liu, ZC; Xie, BF; Yang, D; Zeng, YX; Zhu, XF1

Other Studies

1 other study(ies) available for rtki cpd and Cancer of Nasopharynx

ArticleYear
EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells.
    Cancer letters, 2001, Aug-10, Volume: 169, Issue:1

    Topics: Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; G1 Phase; Growth Inhibitors; Humans; MAP Kinase Signaling System; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Nasopharyngeal Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrphostins; Up-Regulation

2001